ESR1 and breast cancer: To ensure a comprehensive exploration across two BC subtypes, we utilised MCF7 cells, representing the luminal A subtype (ER+, PR+), and HCC1395 cells, which belong to the aggressive TNBC subtype (ER-, PR-, HER2-).